IRBESARTAN VIATRIS 150 mg, tablet 30 tablets, CIP 3400921866643
Active ingredients: Irbesartan
Commercialized according to BDPMDispensing in France: Prescription only
Tablet30 tablets, CIP 3400921866643orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IRBESARTAN VIATRIS 150 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Aug 2012
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61606055CIP72186664CIP133400921866643Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IRBÉSARTANcomprimé | 150 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.